Spina bifida and pediatric cancers

References

• Atta CA, Fiest KM, Frolkis AD, et al. Global birth prevalence of spina bifida by folic acid fortification status: a systematic review and meta-analysis. Am J Public Health. 2016;106(1):e24–34. doi:10.2105/AJPH.2015.302902.
   PubMedGoogle Scholar
• Botto LD, Flood T, Little J, et al. Cancer risk in children and adolescents with birth defects: a population-based cohort study. PLoS One. 2013;8(7):e69077. doi:10.1371/journal.pone.0069077.
   PubMed Web of Science ®Google Scholar
• Fisher PG, Reynolds P, Von Behren J, Carmichael SL, Rasmussen SA, Shaw GM. Cancer in children with nonchromosomal birth defects. J Pediatr. 2012;160(6):978–983. doi:10.1016/j.jpeds.2011.12.006.
   PubMed Web of Science ®Google Scholar
• Lupo PJ, Schraw JM, Desrosiers TA, et al. Association between birth defects and cancer risk among children and adolescents in a population-based assessment of 10 million live births. JAMA Oncol. 2019;5(8):1150. doi:10.1001/jamaoncol.2019.1215.
   Web of Science ®Google Scholar
• Johnson KJ, Lee JM, Ahsan K, et al. Pediatric cancer risk in association with birth defects: A systematic review. PLoS One. 2017;12(7):e0181246. doi:10.1371/journal.pone.0181246.
   PubMed Web of Science ®Google Scholar
• Narod SA, Hawkins MM, Robertson CM, Stiller CA. Congenital anomalies and childhood cancer in Great Britain. Am J Hum Genet. 1997;60(3):474–485.
   PubMed Web of Science ®Google Scholar
• Venkatramani R, Spector LG, Georgieff M, et al. Congenital abnormalities and hepatoblastoma: a report from the Children’s Oncology Group (COG) and the Utah Population Database (UPDB). Am J Med Genet. 2014;164 (9):2250–2255. doi:10.1002/ajmg.a.36638.
   Web of Science ®Google Scholar
• Mertens AC, Wen W, Davies SM, et al. Congenital abnormalities in children with acute leukemia: a report from the Children’s Cancer Group. J Pediatr. 1998;133(5):617–623. doi:10.1016/S0022-3476(98)70100-3.
   PubMed Web of Science ®Google Scholar
• Kajtar P, Weisenbach J, Mehes K. Association of Wilms tumour with spina bifida occulta. Eur J Pediatr. 1990;149(8):594–595. doi:10.1007/BF01957703.
   PubMed Web of Science ®Google Scholar
• Mehes K, Weisenbach J, Kajtar P. Association of Wilms tumor with spinal dysraphism. Pediatr Hematol Oncol. 2003;20(3):261–264. doi:10.1080/08880010390158919.
   PubMed Web of Science ®Google Scholar
• Contreras ZA, Hansen J, Ritz B, Olsen J, Yu F, Heck JE. Parental age and childhood cancer risk: A Danish population-based registry study. Cancer Epidemiol. 2017; 49:202–215. doi:10.1016/j.canep.2017.06.010.
   PubMed Web of Science ®Google Scholar
• Bodin CR, Rasmussen MM, Tabor A, et al. Ultrasound in prenatal diagnostics and its impact on the epidemiology of Spina Bifida in a National Cohort from Denmark with a comparison to Sweden. BioMed Res Int. 2018; 2018:1–8. doi:10.1155/2018/9203985.
   Web of Science ®Google Scholar
• Heck JE, Lee PC, Wu CK, et al. Gestational risk factors and childhood cancers: a cohort study in Taiwan. Int J Cancer. 2020. doi:10.1002/ijc.32905.
   Web of Science ®Google Scholar
• Lin SY, Hsieh CJ, Chen YL, et al. The impact of Down syndrome screening on Taiwanese Down syndrome births: a nationwide retrospective study and a screening result from a single medical centre. PLoS One. 2013;8(9):e75428. doi:10.1371/journal.pone.0075428.
   PubMed Web of Science ®Google Scholar
• Donnan J, Walsh S, Sikora L, Morrissey A, Collins K, MacDonald D. A systematic review of the risks factors associated with the onset and natural progression of spina bifida. Neurotoxicology. 2017; 61:20– 31. doi:10.1016/j.neuro.2016.03.008.
   PubMed Web of Science ®Google Scholar
• Heck JE, He D, Janzen C, et al. Fetal programming and Wilms tumor. Pediatr Blood Cancer. 2019;66(1):e27461. doi:10.1002/pbc.27461.
   PubMed Web of Science ®Google Scholar
• Kauppinen T, Heikkila P, Plato N, et al. Construction of job-exposure matrices for the Nordic Occupational Cancer Study (NOCCA). Acta Oncol. 2009;48(5):791–800. doi:10.1080/02841860902718747.
   PubMed Web of Science ®Google Scholar
• Lowry RB, Bedard T, MacFarlane AJ, Crawford S, Sibbald B, Agborsangaya BC. Prevalence rates of spina bifida in Alberta, Canada: 2001–2015. Can we Achieve More Prevention? Birth Defects Res. 2019;111(3):151–158. doi:10.1002/bdr2.1438.
   PubMedGoogle Scholar
• Seaver LH, Stevenson RE. Syndromes with neural tube defects. In: Wyszynski DF, ed. Neural tube defects: from origin to treatment. Oxford, UK: Oxford University Press; 2006:76–83.
   Google Scholar
• Ostrom QT, Gittleman H, Farah P, et al. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006–2010. Neuro-oncology. 2013;15(suppl 2):ii1–56. doi:10.1093/neuonc/not151.
   PubMed Web of Science ®Google Scholar
• Johnson KJ, Cullen J, Barnholtz-Sloan JS, et al. Childhood brain tumor epidemiology: a Brain Tumor Epidemiology Consortium review. Cancer Epidemiol Biomarkers Prev. 2014;23(12):2716–2736. doi:10.1158/1055-9965.EPI-14-0207.
   PubMed Web of Science ®Google Scholar
• Milne E, Greenop KR, Bower C, Miller M, van Bockxmeer FM, Scott RJ, et al. Maternal use of folic acid and other supplements and risk of childhood brain tumors. Cancer Epidemiol Biomarkers Prev. 2012;21(11):1933–1941. doi:10.1158/1055-9965.EPI-12-0803.
   PubMed Web of Science ®Google Scholar
• Agostini S, Magrini SM, Simoncini R, Biti G, Villari N, Giannardi G. Association between testicular cancer and spina bifida occulta. Acta Oncol. 1991;30(5):579–581. doi:10.3109/02841869109092421.
   PubMed Web of Science ®Google Scholar
• Koen JL, McLendon RE, George TM. Intradural spinal teratoma: evidence for a dysembryogenic origin. Report of four cases. J Neurosurg. 1998;89(5):844–851. doi:10.3171/jns.1998.89.5.0844.
   PubMed Web of Science ®Google Scholar